Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H21Cl2N7O |
| Molecular Weight | 482.365 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1(N)CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(Cl)C=C4)C5=CC=CC=C5Cl
InChI
InChIKey=YBQGLTGAHBCMME-UHFFFAOYSA-N
InChI=1S/C23H21Cl2N7O/c24-14-5-7-15(8-6-14)32-19(16-3-1-2-4-17(16)25)30-18-20(28-13-29-21(18)32)31-11-9-23(27,10-12-31)22(26)33/h1-8,13H,9-12,27H2,(H2,26,33)
| Molecular Formula | C23H21Cl2N7O |
| Molecular Weight | 482.365 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:26:35 UTC 2023
by
admin
on
Sat Dec 16 16:26:35 UTC 2023
|
| Record UNII |
SRU4YD01MF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
686344-31-0
Created by
admin on Sat Dec 16 16:26:35 UTC 2023 , Edited by admin on Sat Dec 16 16:26:35 UTC 2023
|
PRIMARY | |||
|
10480380
Created by
admin on Sat Dec 16 16:26:35 UTC 2023 , Edited by admin on Sat Dec 16 16:26:35 UTC 2023
|
PRIMARY | |||
|
SRU4YD01MF
Created by
admin on Sat Dec 16 16:26:35 UTC 2023 , Edited by admin on Sat Dec 16 16:26:35 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
FECAL
|
||
|
PARENT -> METABOLITE |
URINE
|
||
|
PARENT -> METABOLITE |
MAJOR
PLASMA
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Tmax | PHARMACOKINETIC |
|
IN HEALTHY HUMAN SUBJECTS |
|
||
| Biological Half-life | PHARMACOKINETIC |
|
IN HEALTHY HUMAN SUBJECTS |
|
||